Related Experiment Videos

Glucose metabolism after pancreas-kidney transplantation

Elizabeth Diakoff1

  • 1The Ohio State University, Division of Endocrinology, Diabetes, and Metabolism, 1581 Dodd Drive, 491C McCampbell Hall, Columbus, OH 43210, USA. Elizabeth.Diakoff@osumc.edu

Current Diabetes Reports
|July 18, 2008
PubMed

Insights

Simultaneous pancreas-kidney transplantation offers improved glucose control for type 1 diabetes patients with kidney failure. Long-term monitoring is crucial for beta-cell function and insulin resistance post-transplant.

Area of Science:

  • Nephrology
  • Endocrinology
  • Transplantation Immunology

Background:

  • Type 1 diabetes and end-stage renal disease often coexist.
  • Simultaneous pancreas-kidney (SPK) transplantation is a viable treatment option.
  • SPK transplant can normalize glucose and hemoglobin A1c levels.

Purpose of the Study:

  • To evaluate the long-term outcomes of SPK transplantation.
  • To identify potential complications such as beta-cell dysfunction and insulin resistance.
  • To outline strategies for managing hyperglycemia and graft dysfunction post-transplant.

Main Methods:

  • Assessment of SPK recipients for hyperglycemia.
  • Monitoring for beta-cell function defects.
  • Evaluation of insulin resistance development over time.

Main Results:

  • Significant improvements in glucose and hemoglobin A1c levels are achievable.
  • Patient and graft survival rates are improving.
  • Long-term challenges include beta-cell dysfunction and insulin resistance.

Conclusions:

  • SPK transplantation is effective for managing type 1 diabetes and ESRD.
  • Ongoing monitoring for metabolic complications is essential.
  • Management strategies focus on minimizing diabetogenic immunosuppression and improving insulin sensitivity.

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...